GSK, led by boss Emma Walmsley (pictured), said it would invest $30bn in R&D and supply chain infrastructure over the next five years.Read More

You might also be interested in reading M&A Snapshot: TopBuild CEO expects Progressive Roofing deal to boost non-discretionary revenue.